A multifactorial ‘Consensus Signature’ by in silico analysis to predict response to neoadjuvant anthracycline-based chemotherapy in triple-negative breast cancer

BACKGROUND: Owing to the complex processes required for anthracycline-induced cytotoxicity, a prospectively defined multifactorial Consensus Signature (ConSig) might improve prediction of anthracycline response in triple-negative breast cancer (TNBC) patients, whose only standard systemic treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Natalie, Forcato, Mattia, Nuzzo, Simona, Malorni, Luca, Bicciato, Silvio, Di Leo, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515202/
https://www.ncbi.nlm.nih.gov/pubmed/28721363
http://dx.doi.org/10.1038/npjbcancer.2015.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5515202/
https://www.ncbi.nlm.nih.gov/pubmed/28721363
http://dx.doi.org/10.1038/npjbcancer.2015.3

Ejemplares similares